Ottobock stock pre-market at EUR 49.05: medical technology group slightly lower
Published on 10/28/2026 at 07:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and agenda
- Ottobock develops medical-technology solutions for people with limited mobility.
- The company lists its Q3 2026 quarterly release for November 12, 2026.
- Ottobock stock trades pre-market at EUR 49.05 at 7:49 a.m. CET at Lang & Schwarz on October 28, 2026, 0.20 percent below the Xetra close of October 27, 2026.
Ottobock develops medical-technology solutions for people with limited mobility, according to its investor-relations site. Ottobock stock trades pre-market at EUR 49.05 at 7:49 a.m. CET at Lang & Schwarz on October 28, 2026, 0.20 percent below the Xetra close of October 27, 2026 (EUR 49.15), a comparison supported by TradingView.
Pre-market indication
The indication is EUR 0.10 below the Xetra close. The bid is EUR 48.70 and the ask is EUR 49.40, a spread of 1.43 percent. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Ottobock stock.
Business and upcoming date
The company earns revenue from products and services in prosthetics, neuro-orthotics and exoskeletons, as described by Ottobock investor relations. Its next listed company date is the Q3 2026 quarterly release on November 12, 2026, in Duderstadt. Market context: Market report DAX.
